Skip to main content
Department of Pathology

Research

The main interest of research in our department is the application of recent pathological research methodologies to understand the pathogenesis, improve the diagnosis and predict the prognosis of human disease.

The department collaborates with other clinical departments in different research fields and theses. It also provides research opportunities for postgraduates and staff from the department and from any other discipline both from Egypt and abroad.

The main research facilities available at the department:

  1. Histopathological examination and evaluation of tissues .
  2. Cytopathological assessment of exfoliative and FNA cytology.
  3. immunohistochemical – based researches.

         Research Plan

# Title Research Year
201 Studying of Apoptosis in breast Carcinoma Immunohistochemical studies evaluation of Anti Apoptotic Gene and BCL-2 2011
202 “Lymphatic expression of CLEVER-1in breast cancer and its relationship with lymph node metastasis” 2011
203 The Expression Pattern of Von Hippel-Lindau Tumor Suppressor Protein, MET Proto-oncogene, and TFE3 Transcription Factor Oncoprotein in Renal Cell Carcinoma in Upper Egypt.



2011
204 Prognostic and Predictive Value of P53, Bcl2, Rb and Egfr for Bladder Preservation
in Invasive Bladder Carcinoma Treated by Trimodality Approach
2011
205 Objective assessment of lymphatic and blood vascular invasion in lymph node-negative breast carcinoma: findings from a large case series with long-term follow-up 2011
206 Infantile hemangiopericytoma:Two cases reports and literature review 2011
207 Effect of sildenafil (Viagra) on epidermal growth factor
expression in submandibular gland of diabetic male rats:
histological and immunohistochemical study
2011
208 Clinical significance of elevated alpa feto protein (AFP) in patients with chronic hepatitis C without hepatocellular carcinoma in upper EGYPT 2011
209 Prognostic and Predictive Value of P53, Bcl2, Rb and Egfr for Bladder Preservation in Invasive Bladder Carcinoma Treated by Trimodality Approach 2011
210 Prognostic value of expression of surviving and ki67 in head and neck squamous cell carcinoma treated by chemoradiorherapy 2011